CN103816364A

CN103816364A - Traditional Chinese medicine for treating upper respiratory infection

Info

Publication number: CN103816364A
Application number: CN201210463872.2A
Authority: CN
Inventors: 张文彩
Original assignee: Individual
Current assignee: Individual
Priority date: 2012-11-18
Filing date: 2012-11-18
Publication date: 2014-05-28

Abstract

The invention discloses a traditional Chinese medicine for treating upper respiratory infection, and the traditional Chinese medicine for treating upper respiratory infection is prepared from the following raw materials in parts by weight: 10-20 parts of rhizoma anemarrhenae, 10-20 parts of coptis chinensis, 10-20 parts of liquorice, 10-20 parts of radix bupleuri, 10-20 parts of dandelion, 10-30 parts of lily, 15-35 parts of radix isatidis, 20-30 parts of broadleaf globethistle inflorescence, 20-30 parts of houttuynia cordata, 10-20 parts of Houttuynia cordata, 5-15 parts of platycodon grandiflorum and 40-60 parts of honey. Being scientifically prepared by using pure Chinese herbal medicines as raw materials, the traditional Chinese medicine for treating upper respiratory infection has the functions of ventilating lung qi, preventing phlegm from forming, stopping coughing, relieving asthma, moistening lung and relieving sore throat, has good therapeutic effect on upper respiratory infection, and has the advantages of short therapy course, less possibility for relapse after cure, simplicity in preparation method, good therapeutic effect, safety, no toxic or side effects, convenience for drug use and convenience for carrying.

Description

A kind of Chinese medicine for the treatment of upper respiratory tract infection

Technical field

The invention belongs to the field of Chinese medicines, relate to the medicine for the treatment of respiratory system disease, be specifically related to a kind of Chinese medicine for the treatment of upper respiratory tract infection.

Background technology

Upper respiratory tract infection refers to from nasal cavity to the acutely inflamed general name between throat, is modal infectious disease.90% left and right is caused by virus, after antibacterial infects and is often secondary to viral infection.These disease four seasons, any age all can fall ill, and by containing the virulent spittle, droplet, or propagate through the apparatus polluting.Often in the time that Abwehrkraft des Koepers reduces, as catch cold, tired, the situation such as drench with rain, the former virus having existed or invaded by the external world is or/and antibacterial, ramp breeding, causes infecting.This disease prognosis bona, has self limiting, recovery from illness in general 5～7 days.Chang Jifa bronchitis, pneumonia, nasal sinusitis, a few peoples can complicated with acute myocarditis, nephritis, rheumatic fever etc.

At present, the method for the treatment of upper respiratory tract infection is more, has Western medicine also to have Chinese medicine.Be generally that Western medicine has side effect with the Western medicine of antiinflammatory and the Chinese patent medicine of antitussive, conventional meeting causes the untoward reaction of gastrointestinal, and is that drug price is higher, and medical expense is larger.And Chinese traditional treatment upper respiratory tract infection, therapeutic effect is comparatively slow, and therefore also easily recurrence is not also accepted by extensive patients.

Summary of the invention

The present invention, just for the deficiency of existing treatment upper respiratory tract infection disease technology, provides the Chinese prescription of the effective treatment upper respiratory tract infection of making take vegetable Chinese herbal medicine as raw material of a kind of activity, can treating both the principal and secondary aspects of a disease, have no side effect, prescription is simple, economical and practical, is difficult for recurrence.Based on the traditional Chinese medical science to the pathogenetic research of upper respiratory tract infection and Therapeutic Principle, scientific achievement with reference to modern pharmacological research to treatment by Chinese herbs upper respiratory tract infection, by theory of Chinese medical science prescription, from Chinese herbal medicine, screen, meticulous compatibility, make medicine more directly, fast, fully act on focus, Special medicine for special disease, dialectical treating, safe and reliable.

Technical scheme of the present invention is: a kind of Chinese medicine for the treatment of upper respiratory tract infection, made by the crude drug of following weight proportion: 10～20 parts of the Rhizoma Anemarrhenaes, 10～20 parts of Rhizoma Coptidis, 10～20 parts, Radix Glycyrrhizae, 10～20 parts of Radix Bupleuri, 10～20 parts of Herba Taraxacis, 10～30 parts of Bulbus Liliies, 15～35 parts of Radix Isatidis, 20～30 parts of Flos Echinopsis latifoliis, 20～30 parts of Herba Houttuyniae, 10～20 parts of Fructus Arctiis, 5～15 parts of Radix Platycodoniss, 40～60 parts of Mel.

Further technical scheme is: a kind of Chinese medicine for the treatment of respiratory tract infection, made by the crude drug of following weight proportion: 15 parts of the Rhizoma Anemarrhenaes, 15 parts of Rhizoma Coptidis, 15 parts, Radix Glycyrrhizae, 15 parts of Radix Bupleuri, 15 parts of Herba Taraxacis, 20 parts of Bulbus Liliies, 25 parts of Radix Isatidis, 25 parts of Flos Echinopsis latifoliis, 25 parts of Herba Houttuyniae, 15 parts of Fructus Arctiis, 10 parts of Radix Platycodoniss, 50 parts of Mel.

The invention has the beneficial effects as follows:

1. the present invention, take pure Chinese herbal medicine as raw material, through science preparation, has the function of opening lung-energy, expectorant cough suppressant and anti-asthmatic, moistening lung and nourishing throat.

2. all medicines of the present invention are wanted compatibility, bring out the best in each other, and have heat-clearing and toxic substances removing, YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire, invigorating the spleen and replenishing QI, and dispelling wind and heat pathogens, lung qi dispersing is examined thoroughly, mass dissipating and swelling eliminating, effect of preventing phlegm from forming and stopping coughing, the synergism of drug effect, can treating both the principal and secondary aspects of a disease, to dryness invading the lung, impairment of dispersing and descending function of the lung, lung-dryness syndrome due to deficiency of YIN, clear respectful mistake department, stagnation of QI due to depression of the liver, the poly-expectorant in Tianjin is solidifying, incoordination between the liver and stomach, mechanism of qi superinverse, the caused upper respiratory tract infection of deficiency and exhaustion of liver-YIN has good therapeutic effect, and has treatment short treating period, cures advantages such as being difficult for recurrence.

3. preparation method of the present invention is simple, and therapeutic effect is good, safe without toxic side effect, and medication facilitates, is easy to carry.

The wherein Rhizoma Anemarrhenae: clearing away heat-fire, promotes the production of body fluid and moisturizes.Clearing away heat-fire, promotes the production of body fluid and moisturizes.For fever caused by exogenous pathogenic factors, high hot excessive thirst, lung-heat type cough, osteopyrexia and fever, interior-heat is quenched one's thirst, dryness of the intestine constipation.

Rhizoma Coptidis: heat clearing and damp drying, eliminating fire and detoxication.

Radix Glycyrrhizae: heat-clearing and toxic substances removing, expelling phlegm for arresting cough, gastral cavity abdomen etc.

Radix Bupleuri: expelling pathogenic factors from the exterior expels the heat-evil, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.

Herba Taraxaci: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.

Bulbus Lilii: cold nature is flat, have relieve inflammation or internal heat, lung moistening, the effect of calming the nerves.

Radix Isatidis: the effect with heat-clearing and toxic substances removing, removing heat from blood detumescence, sore-throat relieving.

Flos Echinopsis latifolii: there is relieving cough and asthma, blood pressure lowering, wind-damp dispelling, the effect of eliminating the phlegm, for cold cough, bronchitis, asthma, the diseases such as phlegm dyspnea, rheumatic arthralgia.

Herba Houttuyniae: have heat-clearing and toxic substances removing, effect of inducing diuresis to remove edema, controls pneumonia, lung abscess, tinea alba, the diseases such as scabies.

Fructus Arctii: have dispelling wind and heat pathogens, lung qi dispersing is examined thoroughly, effect of subduing swelling and detoxicating, controls cough due to pathogenic wind-heat, laryngopharynx swelling and pain, the disease such as speckle is examined not saturating, and rubella is had an itch, carbuncle sore tumefacting virus.

Radix Platycodonis: have effect lung qi dispersing, sore-throat relieving, eliminates the phlegm, and effect of evacuation of pus, controls exogenous cough, fullness in the chest and hypochondriac pain, laryngopharynx swelling and pain, the diseases such as lung abscess vomiting pus.

Mel: main cardiopulmonary pathogen, energy settling five organs, main deficiency, invigorating the spleen and replenishing QI, analgesic antidotal, and hundred medicines, can be used for again middle empty epigastric pain and cough due to deficiency of the lung, dryness of the intestine constipation etc.

Above-mentioned all crude drug are parts of generic medicinal plants, in Chinese Pharmacopoeia, are all documented.

The specific embodiment

Treat a Chinese medicine for upper respiratory tract infection, made by the crude drug of following weight proportion: 10～20 parts of the Rhizoma Anemarrhenaes, 10～20 parts of Rhizoma Coptidis, 10～20 parts, Radix Glycyrrhizae, 10～20 parts of Radix Bupleuri, 10～20 parts of Herba Taraxacis, 10～30 parts of Bulbus Liliies, 15～35 parts of Radix Isatidis, 20～30 parts of Flos Echinopsis latifoliis, 20～30 parts of Herba Houttuyniae, 10～20 parts of Fructus Arctiis, 5～15 parts of Radix Platycodoniss, 40～60 parts of Mel.

Further, a kind of Chinese medicine for the treatment of upper respiratory tract infection, is characterized in that, crude drug by following weight proportion is made: 15 parts of the Rhizoma Anemarrhenaes, 15 parts of Rhizoma Coptidis, 15 parts, Radix Glycyrrhizae, 15 parts of Radix Bupleuri, 15 parts of Herba Taraxacis, 20 parts of Bulbus Liliies, 25 parts of Radix Isatidis, 25 parts of Flos Echinopsis latifoliis, 25 parts of Herba Houttuyniae, 15 parts of Fructus Arctiis, 10 parts of Radix Platycodoniss, 50 parts of Mel.

First medicine is washed, use again cold water soak 12 hours, medicine is flooded completely, be convenient to the dissolving of effective ingredient, then medicine is placed in the vessel of marmite, pottery or crock and so on (cannot use iron pan and aluminum pot), add the water for 5～10 times of medicines, or exceed 2～3 centimetres of left and right than powder.While decocting first pass, while being heated to 100 ℃ of left and right, use little fire heating 45 minutes instead all right with big fire, medicine soup is poured in vessel, then decocts second time, the method for decocting second time is the same with first pass, and just the time can be shorter a little.After having decocted, this twice fried medicine soup is mixed and taken, total amount, at 300～500 milliliters, is called in Mel and is stirred evenly, and can make so fully effect between medicine, and effective ingredient stripping is thorough, heightens the effect of a treatment.

Usage: one day potion, be decocted in water for oral dose, can divide and sooner or later take for twice, seven days courses for the treatment of.

Claims

1. a Chinese medicine for the treatment of upper respiratory tract infection, is characterized in that, is made up of the crude drug of following weight proportion: 10～20 parts of the Rhizoma Anemarrhenaes, 10～20 parts of Rhizoma Coptidis, 10～20 parts, Radix Glycyrrhizae, 10～20 parts of Radix Bupleuri, 10～20 parts of Herba Taraxacis, 10～30 parts of Bulbus Liliies, 15～35 parts of Radix Isatidis, 20～30 parts of Flos Echinopsis latifoliis, 20～30 parts of Herba Houttuyniae, 10～20 parts of Fructus Arctiis, 5～15 parts of Radix Platycodoniss, 40～60 parts of Mel.

2. the Chinese medicine for the treatment of upper respiratory tract infection as claimed in claim 1, is characterized in that, is made up of the crude drug of following weight proportion: 15 parts of the Rhizoma Anemarrhenaes, 15 parts of Rhizoma Coptidis, 15 parts, Radix Glycyrrhizae, 15 parts of Radix Bupleuri, 15 parts of Herba Taraxacis, 20 parts of Bulbus Liliies, 25 parts of Radix Isatidis, 25 parts of Flos Echinopsis latifoliis, 25 parts of Herba Houttuyniae, 15 parts of Fructus Arctiis, 10 parts of Radix Platycodoniss, 50 parts of Mel.